127 related articles for article (PubMed ID: 16598765)
1. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins.
Planque N; Long Li C; Saule S; Bleau AM; Perbal B
J Cell Biochem; 2006 Sep; 99(1):105-16. PubMed ID: 16598765
[TBL] [Abstract][Full Text] [Related]
2. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type.
Benini S; Perbal B; Zambelli D; Colombo MP; Manara MC; Serra M; Parenza M; Martinez V; Picci P; Scotlandi K
Oncogene; 2005 Jun; 24(27):4349-61. PubMed ID: 15824736
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.
Bleau AM; Planque N; Lazar N; Zambelli D; Ori A; Quan T; Fisher G; Scotlandi K; Perbal B
J Cell Biochem; 2007 Aug; 101(6):1475-91. PubMed ID: 17340618
[TBL] [Abstract][Full Text] [Related]
4. Functional domains of the TGF-beta-inducible transcription factor Tieg3 and detection of two putative nuclear localization signals within the zinc finger DNA-binding domain.
Spittau B; Wang Z; Boinska D; Krieglstein K
J Cell Biochem; 2007 Jun; 101(3):712-22. PubMed ID: 17252542
[TBL] [Abstract][Full Text] [Related]
5. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor.
Böhlig L; Metzger R; Rother K; Till H; Engeland K
Cell Cycle; 2008 May; 7(9):1254-61. PubMed ID: 18418052
[TBL] [Abstract][Full Text] [Related]
6. Nuclear and cytoplasmic c-Ski differently modulate cellular functions.
Nagata M; Goto K; Ehata S; Kobayashi N; Saitoh M; Miyoshi H; Imamura T; Miyazawa K; Miyazono K
Genes Cells; 2006 Nov; 11(11):1267-80. PubMed ID: 17054724
[TBL] [Abstract][Full Text] [Related]
7. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression.
Fu CT; Bechberger JF; Ozog MA; Perbal B; Naus CC
J Biol Chem; 2004 Aug; 279(35):36943-50. PubMed ID: 15213231
[TBL] [Abstract][Full Text] [Related]
8. Human mitochondrial transcription factor A possesses multiple subcellular targeting signals.
Pastukh V; Shokolenko I; Wang B; Wilson G; Alexeyev M
FEBS J; 2007 Dec; 274(24):6488-99. PubMed ID: 18028422
[TBL] [Abstract][Full Text] [Related]
9. Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies.
Subramaniam MM; Lazar N; Navarro S; Perbal B; Llombart-Bosch A
Virchows Arch; 2008 Jan; 452(1):33-9. PubMed ID: 18066593
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal region of eukaryotic translation initiation factor 5A signals to nuclear localization of the protein.
Parreiras-E-Silva LT; Gomes MD; Oliveira EB; Costa-Neto CM
Biochem Biophys Res Commun; 2007 Oct; 362(2):393-8. PubMed ID: 17707773
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation.
Song JJ; Aswad R; Kanaan RA; Rico MC; Owen TA; Barbe MF; Safadi FF; Popoff SN
J Cell Physiol; 2007 Feb; 210(2):398-410. PubMed ID: 17111364
[TBL] [Abstract][Full Text] [Related]
12. CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
Vallacchi V; Daniotti M; Ratti F; Di Stasi D; Deho P; De Filippo A; Tragni G; Balsari A; Carbone A; Rivoltini L; Parmiani G; Lazar N; Perbal B; Rodolfo M
Cancer Res; 2008 Feb; 68(3):715-23. PubMed ID: 18245471
[TBL] [Abstract][Full Text] [Related]
13. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
[TBL] [Abstract][Full Text] [Related]
14. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
[TBL] [Abstract][Full Text] [Related]
15. N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.
Aoyama E; Hattori T; Hoshijima M; Araki D; Nishida T; Kubota S; Takigawa M
Biochem J; 2009 May; 420(3):413-20. PubMed ID: 19298220
[TBL] [Abstract][Full Text] [Related]
16. A role for CCN3 (NOV) in calcium signalling.
Li CL; Martinez V; He B; Lombet A; Perbal B
Mol Pathol; 2002 Aug; 55(4):250-61. PubMed ID: 12147716
[TBL] [Abstract][Full Text] [Related]
17. The aminoterminal insulin-like growth factor (IGF) binding domain of IGF binding protein-3 cannot be functionally substituted by the structurally homologous domain of CCN3.
Yan X; Baxter RC; Perbal B; Firth SM
Endocrinology; 2006 Nov; 147(11):5268-74. PubMed ID: 16935848
[TBL] [Abstract][Full Text] [Related]
18. The CCN3 (NOV) cell growth regulator: a new tool for molecular medicine.
Perbal B
Expert Rev Mol Diagn; 2003 Sep; 3(5):597-604. PubMed ID: 14510180
[TBL] [Abstract][Full Text] [Related]
19. Ectodysplasin has a dual role in ectodermal organogenesis: inhibition of Bmp activity and induction of Shh expression.
Pummila M; Fliniaux I; Jaatinen R; James MJ; Laurikkala J; Schneider P; Thesleff I; Mikkola ML
Development; 2007 Jan; 134(1):117-25. PubMed ID: 17164417
[TBL] [Abstract][Full Text] [Related]
20. The CCN3 protein and cancer.
Perbal B
Adv Exp Med Biol; 2006; 587():23-40. PubMed ID: 17163153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
